Further data can be gleaned from the study of Tan et al. [21], who reported the mutational analysis of invasive and non-invasive IPMN, which noted frequent mutations in KRAS, GNAS, P53, and RNF 43. This evidence concerns the gene TP53 and pancreatic intraductal papillary-mucinous neoplasm.